[Studies on spasmolytics. VII. Pharmacological properties of 4-benziloyloxy- and 4-(Xanthene-9-carbonyloxy)-1-(1,3-dioxolan-2- ylmethyl)-1- methylpiperidinium salts].
D000818:Animals; D004148:Dioxolanes / Q000494:pharmacology*; D004149:Dioxoles / Q000494:pharmacology*; D006168:Guinea Pigs; D008297:Male; D051379:Mice; D008968:Molecular Conformation; D010276:Parasympatholytics; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014966:Xanthenes / Q000494:pharmacology
D004148:Dioxolanes; D004149:Dioxoles; D010276:Parasympatholytics; D010880:Piperidines; D014966:Xanthenes